Hill_D*A-PP-APRN*

Certified Urology APRN; advanced prostate cancer specialist- WSU Shox Alum 💛🖤🏀🌻- USAR Officer - Miniac 🚘 - Las Vegas Local 🌵🌴😎 - 🎨-tist - 🐶cocker mom

[Dallas Texas TV @DallasTexasTV]

Whale takes a shit at Sea World San Antonio, crowd gets splashed right after

[Hill_D*A-PP-APRN* @hbdursty]

@FlaDogLover @thenewarea51 🤣🤣🤣🤡🤡🤡💀💀

[Hill_D*A-PP-APRN* @hbdursty]

@thenewarea51 The only appropriate reason to bring out the masks 😂😂

[Hill_D*A-PP-APRN* @hbdursty]

@DanielSGTaylor @thenewarea51 😂😂😂😂💀💀💀💀

[UroToday.com @urotoday]

Multi-modal #ArtificialIntelligence (MMAI) prognostic biomarker in high-risk #ProstateCancer. @DrSpratticus @caseccc and @CaPsurvivorship @DanaFarber discuss this test to improve risk stratification and support personalized treatment decisions > https://t.co/Auf7OYNnZq @arteraAI

[UroToday.com @urotoday]

Treatment intensification in metastatic castrate-sensitive #ProstateCancer. @zklaassen_md @GACancerCenter and @WallisCJD @UofT discuss in this UroToday #JournalClub on UroToday > https://t.co/Mx4J9Fv6ZD

[European Association of Urology (EAU) @Uroweb]

🆕 Manage patients with low-risk disease and a life expectancy > 10 years by active surveillance.

#EAUGuidelines #ProstateCancer

https://t.co/0ax5QuNs6e

[UroToday.com @urotoday]

State-Of-The-Art Lecture: #Prostate Biopsy in 2023 – What Should I Know. Presented by @Scarps_kristen @VUMCurology. #SESAUA2023 write coverage by @zklaassen_md @GACancerCenter > https://t.co/V2sfwjeWNq @SES_AUA

[Hill_D*A-PP-APRN* @hbdursty]

@KerithWang @AmerUrological Dick doc ! That’s great !

[UroToday.com @urotoday]

Integrating the use of prostate genomic classifiers into clinical practice - a clinical pathway approach. @KSMurrayUro @NYUUrology and Anne Lizardi-Calvaresi discuss a clinical pathway approach for using the Decipher #ProstateCancer genomic classifier > https://t.co/M8yr7wJzx8

[UroToday.com @urotoday]

Sequencing radiopharmaceuticals: efficacy and safety data of radium-223 followed by lutetium-177-PSMA in the #RALU study. @sartor_oliver @NolaBlueDoo joins @CaPsurvivorship @DanaFarber discuss in this conversation on UroToday > https://t.co/He6UNhEdN7

[European Association of Urology (EAU) @Uroweb]

In patients with urolithiasis, blood analysis must include the measurement of creatinine, uric acid, ionised calcium, sodium, potassium, blood cell count, and C-reactive protein.

#EAUGuidelines #Urolithiasis

https://t.co/a8f4UvH7eX

[Society of Urologic Nurses and Associates @UrologicNurses]

SUNA Patient Fact Sheets provide a wealth of knowledge for many common urologic topics and are available to anyone. https://t.co/uU845wm0kx
#urologic #nurses #UroNurse #UrSoMe #urologicnursing

[Hill_D*A-PP-APRN* @hbdursty]

Dop dop yes yes!! 👀 @tamakoro_6945 @dressupdolllily @Salon_Amaterasu @TomFX4 @WastrelPigs @djcuku @yuruo_crypto @S_G_Dragon @8RjALhix9QSXbln @Obata_Kosuke @mamiyo_mamiyo @hiyakesandal @Kuritaro20 @hosino8807

[Michael Hofman @DrMHofman]

Lutetium-177 PSMA Theranostics: Optimal Sequencing in 2023 and Future Outlook https://t.co/qsS5ptNjeD
#ASCODailyNews @ASCO
Rapidly changing landscape: what do you think is next?

[European Association of Urology (EAU) @Uroweb]

Screen for and treat asymptomatic bacteriuria prior to urological procedures breaching the mucosa.

#uroUTI #eauguidelines

https://t.co/0RhgcZhCkH

[UroToday.com @urotoday]

Treatment intensification in metastatic castrate-sensitive #ProstateCancer. @zklaassen_md @GACancerCenter and @WallisCJD @UofT discuss in this UroToday #JournalClub on UroToday > https://t.co/Mx4J9Fv6ZD

[UroToday.com @urotoday]

The effect of metastasis-directed therapy on oligometastatic castration-sensitive #ProstateCancer outcomes. Philip Sutera, MD @JohnsHopkins joins @CaPsurvivorship @DanaFarber in this conversation on UroToday > https://t.co/j0OK0M9Rtr